$1.53
-0.07[-4.38%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$1.56
0.0300[1.96%]
| Open1.600 | Close1.530 |
| Vol / Avg.68.348K / 33.436K | Mkt Cap19.898M |
| Day Range1.460 - 1.600 | 52 Wk Range1.530 - 4.610 |
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Key Statistics
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) analysis, key statistics.
Valuation Measures
Enterprise Value
10.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.33
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-71.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.48
Tangible Book value per share
0.48
Total Liabilities (Quarterly)
3M
Total Assets
9.2M
Total Liabilities
3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Key Statistics
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) analysis, key statistics.
Valuation Measures
Enterprise Value
10.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.33
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-71.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.48
Tangible Book value per share
0.48
Total Liabilities (Quarterly)
3M
Total Assets
9.2M
Total Liabilities
3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Key Statistics
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) analysis, key statistics.
Valuation Measures
Enterprise Value
10.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.33
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-71.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.48
Tangible Book value per share
0.48
Total Liabilities (Quarterly)
3M
Total Assets
9.2M
Total Liabilities
3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Key Statistics
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) analysis, key statistics.
Valuation Measures
Enterprise Value
10.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.33
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-71.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.48
Tangible Book value per share
0.48
Total Liabilities (Quarterly)
3M
Total Assets
9.2M
Total Liabilities
3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Key Statistics
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) analysis, key statistics.
Valuation Measures
Enterprise Value
10.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.33
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-71.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.48
Tangible Book value per share
0.48
Total Liabilities (Quarterly)
3M
Total Assets
9.2M
Total Liabilities
3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Key Statistics
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) analysis, key statistics.
Valuation Measures
Enterprise Value
10.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.33
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-71.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.48
Tangible Book value per share
0.48
Total Liabilities (Quarterly)
3M
Total Assets
9.2M
Total Liabilities
3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Key Statistics
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) analysis, key statistics.
Valuation Measures
Enterprise Value
10.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.33
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-71.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.48
Tangible Book value per share
0.48
Total Liabilities (Quarterly)
3M
Total Assets
9.2M
Total Liabilities
3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Key Statistics
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) analysis, key statistics.
Valuation Measures
Enterprise Value
10.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.33
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-71.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.48
Tangible Book value per share
0.48
Total Liabilities (Quarterly)
3M
Total Assets
9.2M
Total Liabilities
3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Key Statistics
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) analysis, key statistics.
Valuation Measures
Enterprise Value
10.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.33
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-71.07%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.48
Tangible Book value per share
0.48
Total Liabilities (Quarterly)
3M
Total Assets
9.2M
Total Liabilities
3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -